DiCello Levitt Named Lead Counsel in Shareholder Class Action Against AstraZeneca for Alleged Violations of Federal Securities Laws
SAN DIEGO – March 24, 2025 – The United States District Court for the Central District of California on Friday appointed DiCello Levitt as Lead Counsel in the shareholder class action
